KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：[email protected]
| Catalog Number | YR1022 |
|---|---|
| Product Name | Anti-Human IFNG Recombinant Antibody(Fontolizumab) |
| Molecular Name | Fontolizumab |
| Alias | Anti-IFNG Recombinant Antibody, Research Grade Fontolizumab |
| CAS Number | 326859-36-3 |
| Target | IFNG[Homo sapiens] |
| Isotype | IgG1 |
| Clonity | Monoclonal |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Applications | IF, IP, Neut, FuncS, ELISA, FCM, ICC, Activ, WB |
| Buffer | PBS, pH7.5 |
| Background | Fontolizumab (planned trade name HuZAF) is a humanized monoclonal antibody and an immunosuppressive drug for the treatment of auto-immune diseases like Crohn's disease. A phase II clinical trial investigating the use for rheumatoid arthritis was terminated because the first phase did not meet the endpoint. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：[email protected]
Hot Line： +1-315-239-3085
Technical Support：[email protected]
